Technology
Health
Biotechnology

Athersys

$1.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-6.17%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Athersys and other stocks, options, ETFs, and crypto commission-free!

About

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. Read More The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Employees
75
Headquarters
Cleveland, Ohio
Founded
1995
Market Cap
219.33M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
660.28K
High Today
$1.68
Low Today
$1.51
Open Price
$1.60
Volume
401.33K
52 Week High
$3.09
52 Week Low
$1.36

Collections

Technology
Health
Biotechnology
US
North America

News

Seeking AlphaMar 14

Athersys, Inc. (ATHX) CEO Gil Van Bokkelen on Q4 2018 Results - Earnings Call Transcript

Athersys, Inc. (NASDAQ:ATHX) Q4 2018 Results Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Laura Campbell - Senior Vice President, Finance Gil Van Bokkelen - Chairman and Chief Executive Officer BJ Lehmann - President and Chief Operating Officer Conference Call Participants Katherine Xu - William Blair Chad Messer - Needham and Company Operator Good afternoon. My name is Kelly and I'll be your conference operator today. At this time, I would like to welcome everyone to the...

70
Markets InsiderMar 14

Athersys Announces Financial Results for Fourth Quarter and Full Year 2018

Substantial progress over the year, advancing programs and expanding collaboration with HEALIOS K.K. Management to host conference call at 4:30 PM EST today CLEVELAND, March 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its fourth quarter 2018 and annual 2018 financial results and recent highlights. “As we have announced previously, we had a number of important accomplishments in 2018, including the initiation of our Phase 3 MASTERS-2 study and the expansion of our partnersh...

81
Simply Wall StMar 8

Could The Athersys, Inc. (NASDAQ:ATHX) Ownership Structure Tell Us Something Useful?

Every investor in Athersys, Inc. (NASDAQ:ATHX) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Companies that used to be publicly owned tend to have lower insider ownership. With a market capitalization of US$211m, Athersys is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that i...

4

Earnings

-$0.09
-$0.04
$0.00
$0.05
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.08 per share
Actual
-$0.08 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.